Statin Use and Cognitive Function
Evidence Against Statin-Induced Memory Loss
- The American Diabetes Association and other high-quality guidelines have found no significant association between statin use and cognitive decline in patients with diabetes and high cardiovascular risk 1, 2, 3, 7.
- The European Atherosclerosis Society Consensus Panel statement concluded that several lines of evidence point against an association between statins and cognitive dysfunction in the general population 1.
- Three large randomized trials of statin versus placebo specifically performed cognitive tests, and no differences were seen between statin and placebo groups, suggesting no adverse effect of statins on cognition 1, 3, 4.
- The U.S. Preventive Services Task Force (USPSTF) found no clear evidence of decreased cognitive function associated with statin use in adults 5, 6.
Clinical Implications
- The American College of Cardiology/American Heart Association Task Force on Practice Guidelines found no evidence that statins had an adverse effect on cognitive changes or risk of dementia in patients with high cardiovascular risk 2.
- The benefits of statins for cardiovascular risk reduction far outweigh any potential cognitive risks, especially in high-risk populations, according to the American College of Cardiology and the American Heart Association 5, 8.
- The Diabetes Care guidelines specifically state that fear of cognitive decline should not be a barrier to statin use in individuals with diabetes and high cardiovascular risk, as the evidence for cardiovascular benefit is robust 3, 7, 9.